Patients with diabetes mellitus have a higher risk of complications after sustaining an ankle fracture, including fracture displacement, superfi cial and deep infection, hardware failure, and neuropathic arthropathy. With the increased incidence of diabetes among the aged, the increased incidence of complications due to diabetes mellitus and its sequelae are important to keep in mind when treating ankle fractures.
A nkle fractures are one of the most common orthopedic injuries. More than 260,000 ankle fractures are diagnosed annually in the United States, and these numbers are increasing as the population ages. Approximately one-quarter of all ankle fractures are treated surgically. With the increased incidence of diabetes among the aged, the increased incidence of complications due to diabetes mellitus and its sequelae are important to keep in mind when treating ankle fractures.
DIABETES MELLITUS
Diabetes mellitus is a growing problem in public health today. According to the Centers for Disease Control, 25.8 million people in the United States had this disease in 2010, representing 8.3% of the population. Of these people, 18.8 million carry a known diagnosis and 7 million are undiagnosed. In the elderly, 26.9% have the disease, amounting to 10.9 million people. One point nine million new cases of diabetes are diagnosed every year. 1 The prevalence of diabetes between 1990 and 2001 has increased 61% and shows no signs of slowing. In fact, it has been estimated that between 2000 and 2050, the prevalence will increase by 165%, with higher rates of increase among the elderly and minorities. 2 The world population of diabetics is expected to swell to 366 million by 2030. 3 The risk of developing diabetes through the course of a person's lifetime in the United States in 2000 was estimated to be 32.5% for men and 38.5% for women. This risk is higher for minorities, especially Hispanics. Diagnosis of type 2 diabetes has been associated with decreased life expectancy of 14.3 life-years in women and 11.6 life-years in men. In addition to decreased life expectancy, a decrease of quality-adjusted life-years of 22.0 for women and 18.6 for men has been predicted. 4 Diabetes mellitus refers to a group of metabolic disorders resulting in systemic hyperglycemia. The 2 main categories of the disease are type 1 diabetes, caused by autoimmune destruction of insulin producing ␤-cells in the pancreas, and type 2 diabetes, caused by a combination of increased peripheral insulin resistance and decreased insulin production by the ␤ cells in the pancreas. The diagnosis of diabetes mellitus is contingent on 1 of 4 criteria:
1. Fasting plasma glucose у126 mg/dL. 2. Elevated random glucose levels of у200 mg/dL with associated symptoms of hyperglycemia, including polyuria, polydipsia, and unexplained weight loss. 3. A positive glucose challenge test, resulting in a blood sugar of у200 mg/dL. 4. An elevated hemoglobin A1c Ͼ6.5%.
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The end result of diabetes is systemic hyperglycemia. This hyperglycemia leads to the glycosylation of proteins throughout the body and intracellular formation of sorbitol and other alcohols. This hyperglycemic state also disrupts the regulation of reactive oxygen species (such as peroxides and oxygen ions), which leads to large amounts of these reactive ■ trauma update oxygen radicals being formed. These reactive oxygen species damage cellular proteins, membrane lipids, and nuclear material, leading to increased levels of apoptosis. Decreased nitrous oxide production leads to vasoconstriction, nerve ischemia and decreased production of neurotrophic factors. All of these effects lead to the common sequelae of poorly controlled diabetes: peripheral neuropathy, vasculopathy, nephropathy, immune dysfunction, and retinopathy. 6 Peripheral neuropathy is a common complication of uncontrolled diabetes. Approximately 10% of diabetics have some element of neuropathy on presentation and 40% will be diagnosed with neuropathy within 1 year. More than half of all diabetics older than 60 years have some element of neuropathy. Peripheral neuropathy is diagnosed using the 10-g (5.07) nylon SemmesWeinstein monofi lament test, which has a sensitivity of up to 91% and a specifi city of up to 86%. [7] [8] [9] A 128-Hz tuning fork may also be used to test the sensitivity of the extremities to vibration, and may be more sensitive for early neuropathy. 10 Vasculopathy is another common complication of uncontrolled diabetes. Both the large and small arteries are affected, as well as the microcirculation. 11 This leads to diffi culties with oxygen transport and localized tissue ischemia. The impaired wound healing seen in uncontrolled diabetics is due to diffi culties in collagen production and cross-linking, as well as defi ciencies of fi broblast function in an ischemic environment. 12 Diabetics also have more aggressive and diffuse atherosclerosis than the average person, and after 20 years of having active diabetes, Ͼ45% of patients have some element of atherosclerosis. with noted end-organ damage such as peripheral artery disease, nephropathy, or peripheral neuropathy, and 59 with diabetes mellitus and no endorgan damage. They followed the patients for an average of 21 months. Their analysis showed that patients with complicated diabetes mellitus had an increased risk of any complication (odds ratio, 3.8), noninfectious complications (odds ratio, 3.4), and revision surgery (odds ratio, 5.0). They noted that most complications were unrecognized by the patients themselves.
OUTCOMES RESEARCH IN DIABETICS WITH ANKLE FRACTURES
15 Common complications noted in many studies include higher rates of postoperative infections, diffi culty with wound healing, and development of Charcot arthropathy. Soo Hoo et al 16 looked at all patients who had surgery for an ankle fracture according to the California discharge database between 1995 and 2005. A total of 57,193 patients fi t into this group and were evaluated for their rates of short-term complications, such as mortality and infection, and intermediate-term complications, such as revision or arthrodesis. Overall, rates of short-term complications, such as pulmonary embolus (0.34%), mortality (1.07%), amputation (0.16%), and infection (1.44%) were low. Similarly, rates of intermediate complications such as revision (0.82%) and arthrodesis/ankle replacement within 5 years (0.96%) were also noted to be relatively low. However, the presence of complicated diabetes (odds ratio, 2.3) and peripheral vascular disease (odds ratio, 1.65) were shown to be indicators of signifi cantly increased risk of both shortand intermediate-term complications. 16 
INFECTION
Infection has been a problem for diabetics treated either conservatively or surgically. Flynn et al 17 retrospectively compared the treatment of closed ankle fractures in 73 nondiabetic patients and 25 patients with diabetes mellitus. They found that the risk of infection was 4 times as great in the diabetic group (32%) as compared to the patients who were not diabetic (8%). Diabetic patients who were treated surgically had twice the infection rate of nondiabetics. Even diabetic patients who were treated in a cast had a 66% infection rate. Diabetic patients with peripheral vascular disease, peripheral neuropathy, swelling and/or ecchymosis, or who were poorly compliant had increased risks of infection. 
TREATMENT SUPPLEMENTATION OPTIONS
Unstable ankle fractures in diabetics should be treated surgically, through traditional open reduction and internal fi xation. However, recommendations have been made in 3 papers describing methods of supplemental fi xation.
Schon and Marks 22 recommended avoiding the use of bone-holding clamps and using either manual traction or a femoral distractor to assist with the reduction. Bony fragments should be reduced with Kirschner wires. Because of the poor bone quality of the diabetic patient, as well as the concomitant healing and vascular problems, every attempt should be made to maintain the periosteal blood supply to the fracture fragments and to not further fracture them through rough handling. They stated that it may be necessary to place screws into the tibia from the fi bular fi xation for greater stability, as the bony strength of the fi bula may not be suffi cient to hold screws well. On the medial side, it may be necessary to use a 2-or 3-hole plate in a neutralization or buttress mode to supplement other fi xation in the medial malleolus. Syndesmotic injuries should be fi xed with 1 or 2 tetracortical screws for increased stiffness and stability. 22 Jani et al 28 looked at a series of 15 patients (16 ankles) with noted diabetic neuropathy and unstable ankle fractures who were treated operatively and then followed for an average of 69 weeks. They were treated with traditional open reduction and internal fi xation, which was supplemented with retrograde trans calcaneal-talartibial fi xation with Steinman pins or large screws. Postoperatively, they were made nonweight bearing for 12 weeks in a short-leg total contact cast. This was removed, along with the Steinman pins or large screws, at 12 to 16 weeks, and the patient was then placed in a short-leg cast or a boot and made partial weight bearing for an additional 12 weeks. After completing this course of partial weight bearing, they were allowed to bear weight as tolerated, but wore an ankle-foot orthosis or total contact inserts. Twelve of the ankles were able to bear weight at follow-up and could walk without diffi culty. There were 4 deep infections in the other ankles, 2 requiring ■ trauma update irrigation and debridement and 2 requiring transtibial amputation. 28 Perry et al 29 looked at a series of 6 patients with noted diabetic neuropathy who presented for treatment of the failed traditional fi xation of their Weber B and C ankle fractures. Five of the patients had neuropathy secondary to diabetes mellitus and 1 secondary to alcoholism. Five of the 6 fractures were due to trauma and 1 presented without an antecedent trauma. All were treated with a laterally placed 4.5 dynamic compression plate on the fi bula with multiple 4.5-mm tetracortical syndesmotic screws. The patients remained nonweight bearing in a shortleg cast for a minimum of 3 months. At follow-up, the patients were satisfi ed with their well-aligned, functional limbs. There were no amputations within this group, resulting in a 100% salvage rate.
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CHARCOT TREATMENT OPTIONS
Several methods have been described for the treatment of Charcot arthropathy. Initial treatment usually starts conservatively. Patients are put into a total contact cast or a Charcot restraint orthotic walker boot for immobilization while they are in the initial destructive stage of their neuroarthropathy. After they show signs of moving into the coalition phase, with commensurate decrease in edema, erythema, and hyperemia, they are switched to a removable bivalved ankle-foot orthosis. After the consolidation phase has fi nished and they have moved into the resolution phase, they are placed into custom-molded, dual-density accommodative insoles to decrease the contact pressure on bony prominences. Remaining areas of high pressure due to collapse of the foot architecture can be addressed by an exostectomy of the bony prominences. However, aggressive excision should be avoided to preserve joint stability. 30 Arthodesis is the salvage treatment of Charcot neuroarthropathy. The primary indication for arthrodesis is to retain a foot or leg threatened by damage to its soft tissue envelope. Formation of a stable arthrodesis can be challenging, as the pathophysiology of diabetes mellitus and that of the neuropathic arthropathy itself do not lend themselves to the formation of good bone. Papa et al 31 looked at 29 patients with Charcot arthropathy, of which 21 cases were of the ankle. These were all managed with open reduction and arthrodesis: 25 through rigid internal fi xation and 4 through the use of external fi xation. All patients were nonweight bearing for 4 to 14 months in a total contact cast. After an average 42-month follow-up, 20 patients went on to fusion and 7 went on to a stable pseudoarthrosis, for a successful salvage in 93% of patients. Unfortunately, this study noted many complications among its participants, including 1 incidental mortality, 1 transtibial amputation for fi xation failure, 3 revisions of fi xation, 2 malunions, 8 skin problems (sloughs/ulceration), and 3 superfi cial infections. 31 Pinzur and Noonan 32 looked at 9 patients with Charcot arthropathy of the ankle who underwent ankle arthrodesis with a retrograde femoral nail. At 10.5 weeks, fusion was noted on radiographs. All patients were ambulatory at an average 32-week follow-up. 32 Dalla Paola et al 33 looked at 18 patients with Charcot neuroarthropathy who were treated with retrograde transcalcaneal nailing. Subsequent to their surgery, they were made nonweight bearing for 3 months, followed by partial weight bearing for an additional 3 months. At an average 14-month follow-up, 14 patients had a stable fusion and the 4 remaining patients had fibrous unions, thus resulting in a 100% limb salvage rate. 33 Fabrin et al 34 described using a compressive external fi xator as the means for achieving arthrodesis. They looked at 11 patients (12 ankles) with unstable or malaligned Charcot ankles with noted plantar ulceration. All were treated with arthrodesis, 7 tibiotalar and 5 tibiocalcaneal. Postoperatively, they were kept in compression via the external fi xator for 5 weeks, then converted to a total contact cast for 6 weeks. They were allowed to bear weight at 12 weeks in a brace. At followup, 1 ankle had gone on to a transtibial amputation secondary to a loosened pin. The other 11 feet were able to independently walk with a brace, for a 92% limb salvage rate.
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Figure 1:
A 57-year-old woman with diabetes, peripheral neuropathy, vasculopathy, end-stage renal failure managed by peritoneal dialysis, aortic stenosis, hypertension, and hyperlipidemia sustained a minimally displaced bimalleolar fracture in a fall. Because of her poor medical condition, she was initially treated by closed methods (A, B) . The patient's fracture went on to displace despite casting and maintaining nonweight bearing (C, D). Ten weeks after the initial injury, the patient underwent subtalar and ankle arthrodesis with an intramedullary device. This method was chosen because of the patient's poor bone quality and medical condition (E, F). 
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OUR PREFERRED TREATMENT
Since diabetic patients with bimalleolar, trimalleolar, or ankle subluxation are at high risk for further displacement, we usually fi x these fractures even if the initial reduction is acceptable (Figure 1) . Because of the prolonged healing time due to poor vascularity and the high incidence of neuropathy, we keep the patients nonweight bearing for up to 12 weeks and protect them in a cast brace or ankle-foot orthosis for an additional 4 to 8 weeks. Patients are seen in the offi ce initially at weekly intervals and then biweekly to monitor the wound for breakdown and the fracture position radiographically. We maintain the restricted weight bearing based on the postoperative time interval, even if the fracture appears to be healing satisfactorily.
Because diabetic patients usually have poor bone quality, we tend to use heavier plates and plates with locking screws (Figure 2) . Finally, although not proven in the literature, we tend toward multiple screws from the fi bular into the tibia, especially in cases of syndesmotic disruption (Figure 3 ). A 71-year-old man with a long history of type 2 diabetes, well-controlled on insulin, without signifi cant peripheral neuropathy and with good bone quality and no other signifi cant comorbidities sustained a Weber B type ankle fracture-dislocation (A, B). Fracture fi xation was performed using a heavy small fragment plate. The syndesmosis was stable, so we did not use transtibial (syndesmotic) screws. However, the patient was kept nonweight bearing for a full 12 weeks postoperatively, and then partial weight bearing in a brace for an additional 4 weeks (C, D). 
